Bisphenol A triggers activation of ocular immune system and aggravates allergic airway inflammation

IF 4.5 3区 医学 Q2 IMMUNOLOGY Clinical immunology Pub Date : 2024-09-28 DOI:10.1016/j.clim.2024.110370
Tatsuo Ueda , Takumi Adachi , Tomoya Hayashi , Koubun Yasuda , Kazufumi Matsushita , Eiko Koike , Rie Yanagisawa , Takahiro Nagatake , Jun Kunisawa , Ken J. Ishii , Kenzo Tsuzuki , Etsushi Kuroda
{"title":"Bisphenol A triggers activation of ocular immune system and aggravates allergic airway inflammation","authors":"Tatsuo Ueda ,&nbsp;Takumi Adachi ,&nbsp;Tomoya Hayashi ,&nbsp;Koubun Yasuda ,&nbsp;Kazufumi Matsushita ,&nbsp;Eiko Koike ,&nbsp;Rie Yanagisawa ,&nbsp;Takahiro Nagatake ,&nbsp;Jun Kunisawa ,&nbsp;Ken J. Ishii ,&nbsp;Kenzo Tsuzuki ,&nbsp;Etsushi Kuroda","doi":"10.1016/j.clim.2024.110370","DOIUrl":null,"url":null,"abstract":"<div><div>Bisphenol A (BPA) is widely used in manufacturing plastic products, and it has been reported that exposure through the airway or orally aggravates allergic airway inflammation. Because BPA is detected in the atmosphere and indoor environments, the eyes can also be exposed to BPA. After ocular exposure to BPA and antigen via eye drops, we observed enhanced antigen uptake of antigen-presenting cells (APCs) in tear duct-associated lymphoid tissue (TALT). Additionally, we observed the formation of germinal center (GC) B cells in TALT and induction of allergic airway inflammation in mice sensitized with BPA and antigen via eye drops, followed by airway antigen exposure. We also found that DNAX-activating protein of 12 kDa (DAP12)-deficient mice displayed impaired activation of APCs enhanced by ocular exposure to BPA. These results indicate that ocular sensitization to BPA and allergen triggers allergic inflammation via TALT activation, and that DAP12 might be a key molecule for modulating the ocular immune system.</div></div>","PeriodicalId":10392,"journal":{"name":"Clinical immunology","volume":"268 ","pages":"Article 110370"},"PeriodicalIF":4.5000,"publicationDate":"2024-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical immunology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1521661624004790","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Bisphenol A (BPA) is widely used in manufacturing plastic products, and it has been reported that exposure through the airway or orally aggravates allergic airway inflammation. Because BPA is detected in the atmosphere and indoor environments, the eyes can also be exposed to BPA. After ocular exposure to BPA and antigen via eye drops, we observed enhanced antigen uptake of antigen-presenting cells (APCs) in tear duct-associated lymphoid tissue (TALT). Additionally, we observed the formation of germinal center (GC) B cells in TALT and induction of allergic airway inflammation in mice sensitized with BPA and antigen via eye drops, followed by airway antigen exposure. We also found that DNAX-activating protein of 12 kDa (DAP12)-deficient mice displayed impaired activation of APCs enhanced by ocular exposure to BPA. These results indicate that ocular sensitization to BPA and allergen triggers allergic inflammation via TALT activation, and that DAP12 might be a key molecule for modulating the ocular immune system.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
双酚 A 会引发眼部免疫系统激活,加重过敏性气道炎症。
双酚 A(BPA)被广泛用于制造塑料产品,据报道,通过呼吸道或口服接触双酚 A 会加重过敏性气道炎症。由于大气和室内环境中都能检测到双酚 A,因此眼睛也可能接触到双酚 A。通过滴眼液将双酚 A 和抗原暴露于眼部后,我们观察到泪管相关淋巴组织(TALT)中的抗原呈递细胞(APC)对抗原的吸收增强。此外,我们还观察到泪管相关淋巴组织(TALT)中形成了生殖中心(GC)B 细胞,并通过滴眼液诱导了对双酚 A 和抗原过敏的小鼠的过敏性气道炎症。我们还发现,DNAX-活化蛋白 12 kDa(DAP12)缺陷小鼠在眼部暴露于双酚 A 的情况下,APCs 的活化能力受损。这些结果表明,眼部对双酚 A 和过敏原的致敏会通过 TALT 激活引发过敏性炎症,而 DAP12 可能是调节眼部免疫系统的关键分子。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Clinical immunology
Clinical immunology 医学-免疫学
CiteScore
12.30
自引率
1.20%
发文量
212
审稿时长
34 days
期刊介绍: Clinical Immunology publishes original research delving into the molecular and cellular foundations of immunological diseases. Additionally, the journal includes reviews covering timely subjects in basic immunology, along with case reports and letters to the editor.
期刊最新文献
A randomised, placebo-controlled, phase III trial of leniolisib in activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS): Adolescent and adult subgroup analysis. Clinical characterization of NOD2 variants in patients with common variable immunodeficiency. HLA evolutionary divergence effect on bacterial infection risk in cirrhotic liver transplant candidates. Optimizing iNKT-driven immune responses against cancer by modulating CD1d in tumor and antigen presenting cells. Comparative analysis of the B cell receptor repertoire during relapse and remission in patients with multiple sclerosis.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1